Harrison.ai, a global leader in clinical artificial intelligence, today announced it now holds three FDA Breakthrough Device Designations for CT imaging solutions, further solidifying its position at the forefront of next-generation AI for driving efficient, quality patient care.

Smith+Nephew, the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT)

Bunkerhill Health has received U.S. Food and Drug Administration (FDA) clearance for Bunkerhill MAC, the first artificial intelligence algorithm designed to detect and quantify mitral annular calcification (MAC) using routine, non-gated chest CT scans.

Cagent Vascular, a leader in endovascular technologies, has announced the commercial launch of the Serranator® PTA Serration Balloon Catheter in 7.0 mm and 8.0 mm diameters. The new sizes extend the benefits of serration technology

Tosoh Bioscience, Inc., a market leader in clinical diagnostics is proud to announce that it has received US FDA 510(k) clearance for its next-generation system for HbA1c testing - the Tosoh Automated Glycohemoglobin Analyzer

Moneta Health, a brain health company pioneering cognitive rehabilitation therapy through AI-powered delivery, today announced a $4.5 million funding round and a new partnership with Benefis Health System to expand access to cognitive care in neurology deserts. The company has signed a multi-year partnership

NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, is expanding its patient engagement offerings with the introduction of NextGen® Navigator, a new AI-driven customer

ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. today jointly announced an agreement leveraging KORU Medical’s FreedomEDGE® infusion system as part of ForCast’s technology platform for the treatment of periprosthetic joint infection (PJI). PJI is a rare but serious complication

AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ GuardTM, an FDA Breakthrough Device Designated AI-powered technology that enables the detection of hyperkalemia using Lead I ECG. The three-arm prospective pilot study

Doctronic, the AI-native platform delivering fast, private, and personalized healthcare at scale, today announced a $20 million Series A round led by Lightspeed Venture Partners, with participation